Does cognitive decline contribute to poorer quality of life in incident Parkinson’s disease? A three year follow up
Objective: To investigate the impact of cognition and cognitive decline on quality of life (QoL) in an incident Parkinson's disease (PD) cohort over three years.…Interrelation between gait impairment with cognitive disturbances in patients with Parkinson’s disease
Objective: To study interrelation of neuropsychological disturbances with severe gait impairment and postural stability in Parkinson's disease. Background: Clinical features of gait impairment and postural…Neuropsychological subgroups in non-demented Parkinson’s disease: A latent class analysis
Objective: Identify discrete cognitive phenotypes in a cohort of 199 non-demented Parkinson's disease (PD) patients. Background: Methods to detect early cognitive decline and account for…Validation of the Seoul-instrumental activity of daily living in the detection of dementia in Parkinson’s disease
Objective: Seoul instrumental activity of daily living (S-iADL) scale is well known to the tool for instrumental activities of Korean elders. However, cutoff point of…Impact of sociodemographic and clinical characteristics on cognition of individuals with Parkinson’s disease
Objective: Correlate cognitive function, clinical characteristics and sociodemographic status with the staging of PD. Background: Introduction: Evidences point the occurrence of cognitive impairment in all…Neuroanatomical correlates of apathy in non-demented and non-depressed Parkinson’s disease
Objective: We aimed to explore the neuroanatomical correlates of isolated apathy in PD by means of voxel-based morphometry (VBM) analysis and its correlates with other…Prevalence of impulse control disorders among adult Filipino patients with idiopathic Parkinson’s disease seen at a tertiary center in Manila
Objective: (1) To determine the prevalence and severity of Impulse Control Disorders (ICDs) in adult Filipino patients with idiopathic Parkinson's disease seen at a tertiary…EARLYSTIM: STN-DBS alleviates behavioural side effects of dopamine replacement therapy when compared to best medical treatment
Objective: To compare effects of STN-DBS and dopamine replacement therapy (DRT) on behaviour in PD in a 2 year follow-up study. Background: A large panel…Anhedonia and its correlation with clinical aspects in Parkinson’s disease
Objective: The aim of this study is to evaluate the characteristics of anhedonia and its correlation with clinical aspects of PD in a relatively large…Dementia in Parkinson’s disease: Is male gender a risk factor?
Objective: We investigated the relationship between dementia and gender along with other established risk factors, such as age and disease duration. Background: The rates of…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.